Back to results
US 2003/0143265 A1Published application
Method for treatment of sepsis
OwnerSeiichi Araki, Akira Kato +1inventors
InventorsSeiichi Araki, Akira Kato, Katsumi Onai
Life of this patent
Estimating the term…
Abstract
It has unexpectedly been found that the administration of high doses of riboflavin or derivatives thereof (including, but not limited to salts and prodrugs), results in an effective treatment for sepsis. Thus, the present invention provides methods for treating sepsis by administering to a subject in need thereof a high dose of a composition comprising riboflavin or derivatives thereof.
Claims12
A method for treating sepsis comprising administering to a subject in need thereof greater than about 1.8 mg/kg of body weight per day of a composition comprising riboflavin or derivatives thereof.
Dependencies are inferred from the claim text.